Risk for Emergence of Dengue and Chikungunya Virus in Israel
Eyal Leshem, Hanna Bin, Uri Shalom, Maayan Perkin, and Eli Schwartz
Author affiliations: The Chaim Sheba Medical Center, Tel Hashomer, Israel (E. Leshem, E. Schwartz); Tel Aviv University, Tel Aviv, Israel (E. Leshem, E Schwartz); Ministry of Health, Tel Hashomer (H. Bin); Ministry of Environmental Protection, Jerusalem, Israel (U. Shalom, M. Perkin)
Figure. Patients with imported dengue (black circles) or chikungunya (black triangles) virus infection living in Aedes albopictus–endemic areas of Israel, 2008–2010. Gray shading indicates known and black outline suspected A. albopictus–endemic areas. Of the patients with dengue and chikungunya virus disease, 66% (27/41) and 80% (12/15), respectively, lived in A. albopictus–endemic areas.
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.